Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 238,190 |
|
|||||
| News | - | ||||||
| Day High | 6.56 | Low High |
|||||
| Day Low | 6.19 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Larimar Therapeutics Inc | LRMR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.13 | -1.99% | 6.40 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.53 | 6.19 | 6.56 | 6.40 | 6.53 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,148 | 238,190 | $ 6.40 | $ 1,525,468 | - | 2.18 - 13.68 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:02:31 | formt | 4,904 | $ 6.40 | USD |
Larimar Therapeutics (LRMR) Options Flow Summary
Larimar Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 63.16M | 63.80M | - | 0 | -36.95M | -0.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Larimar Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LRMR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.96 | 7.37 | 6.18 | 6.82 | 398,571 | -0.56 | -8.05% |
| 1 Month | 8.01 | 8.17 | 6.18 | 7.21 | 412,495 | -1.61 | -20.10% |
| 3 Months | 4.90 | 13.68 | 4.88 | 9.65 | 680,473 | 1.50 | 30.61% |
| 6 Months | 2.87 | 13.68 | 2.18 | 8.66 | 386,195 | 3.53 | 123.00% |
| 1 Year | 4.47 | 13.68 | 2.18 | 6.74 | 315,848 | 1.93 | 43.18% |
| 3 Years | 10.80 | 15.49 | 1.53 | 6.22 | 208,602 | -4.40 | -40.74% |
| 5 Years | 12.00 | 25.87 | 1.53 | 6.92 | 170,735 | -5.60 | -46.67% |
Larimar Therapeutics Description
| Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia. |
